Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Pritam Thapa, Sunil P. Upadhyay, Vikas Singh, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 7, pp. 100100-100100
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
Shengying Lou, Miaolian Wu, Sunliang Cui
Current Medicinal Chemistry (2024) Vol. 31, Iss. 15, pp. 2021-2051
Closed Access | Times Cited: 5
Structure-based design and synthesis of sulfonylureas as novel NLRP3 inhibitors for Alzheimer’s disease
Eun Young Kim, Jae Hong Im, Jinhe Han, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129622-129622
Closed Access | Times Cited: 4
NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development
Inamul Haque, Pritam Thapa, Douglas M. Burns, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6078-6078
Open Access | Times Cited: 4
Synthesis of bioisosteres of caffeic acid phenethyl ester: 1,3,4-oxadiazole derivatives containing a catechol fragment with anti-inflammatory activities in vitro and in vivo
Jing Sun, Yichuan Ran, Yongfu Wang, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108123-108123
Closed Access
Development of a bio-inspired phagocytic stable nanoghost with anti-inflammatory properties for management of inflammation in ulcerative colitis
Ahmed Mohsin Huran Al-Jawadri, Zahra Karami, Ismaeil Haririan, et al.
Journal of drug targeting (2025), pp. 1-15
Closed Access
Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3
I‐Cheng Chen, Wan-Ling Chen, Kuo‐Hsuan Chang, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176370-176370
Open Access | Times Cited: 2
Exploring 4-chloro chalcone: Synthesis, spectroscopic, chemical reactivity, topological, hirshfeld surface, drug-Likeness, molecular docking and assessment of electronic properties in diverse solvents
P. Chakkaravarthy, J. Glory, C. S. Manikandababu, et al.
Journal of Molecular Liquids (2024) Vol. 400, pp. 124561-124561
Closed Access | Times Cited: 2
Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
Ciara Campbell, Jay M Mayatra, Ashish Neve, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 5, pp. 670-679
Open Access | Times Cited: 2
Deep-Learning-Driven Discovery of SN3–1, a Potent NLRP3 Inhibitor with Therapeutic Potential for Inflammatory Diseases
Cheng Shi, Tongfei Gao, Weiping Lyu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17833-17854
Closed Access | Times Cited: 2
Libertellenone C attenuates oxidative stress and neuroinflammation with the capacity of NLRP3 inhibition
Jie Cao, Lanqin Li, Runge Zhang, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pyridazine Derivatives as NLRP3 Inhibitors for Treating Asthma, COPD, Parkinson’s Disease, and Alzheimer’s Disease
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1047-1048
Open Access | Times Cited: 3
Elucidating Molecular Mechanism and Chemical Space of Chalcones through Knowledge Graph and Machine Learning: A Combined Bio-Cheminformatic Pipeline
Ajay Manaithiya, Ratul Bhowmik, Satarupa Acharjee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease
Te‐Hsien Lin, Ya‐Jen Chiu, Chih‐Hsin Lin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Synthesis, biological evaluation and molecular dynamics simulations of new sulfonylurea derivatives bearing biphenyl moieties as potential NLRP3 inhibitors
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Is there a place for natural agents with anti-inflammatory and antioxidative properties in critically ill patients? Potential usefulness of Xanthohumol
Wojciech Dąbrowski, Carmen A. Pfortmueller, Katarzyna Kotfis, et al.
Pharmacology & Therapeutics (2024), pp. 108766-108766
Closed Access
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 895-896
Open Access | Times Cited: 1
Recent Updates on Synthetic Strategies of Chalcone Scaffold and their Heterocyclic Derivatives
Mohamed A. Amin, Montaser Shaykoon Ahmed Shaykoon, Adel A. Marzouk, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 124-132
Open Access | Times Cited: 1
1,2,4-Triazine Derivatives as NLRP3 Inhibitors for Treating Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 547-548
Open Access
Investigating the Therapeutic Effects of Novel Compounds Targeting Inflammasome and IL-1β and IL-6 Signaling Pathways in Spinocerebellar Ataxia Type 3
I‐Cheng Chen, Wan-Ling Chen, Kuo‐Hsuan Chang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top